Financials
Financial year 2025
Klinisch Biologen ZAS from Antwerpen, company number BE0803393986, closed financial year 2025 with a result of € 0 after tax. For that financial year Klinisch Biologen ZAS recorded a gross margin of € 2,845 and equity of € 21,000. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 21,000
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 237,982
▼ 3% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 0.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,953
▼ 63% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 623
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 922 | € 2,845 | ▲ 208% |
| Equity | € 21,000 | € 21,000 | |
| Total debts | € 1,889,113 | € 1,194,512 | ▼ 37% |
| Cash | € 246,455 | € 237,982 | ▼ 3% |
| Balance sheet total | € 1,910,113 | € 1,215,512 | ▼ 36% |
Key figures of Klinisch Biologen ZAS, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Klinisch Biologen ZAS?
What happened at Klinisch Biologen ZAS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
In short
From € 0 profit in 2024 to € 0 profit in 2025.
Paid € 2,211 in corporate taxes since 2024.
A new publication or filing at Klinisch Biologen ZAS? We notify you, reason included.
Follow Klinisch Biologen ZASDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DR. K. CAMPS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Klinisch Biologen ZASBehind Klinisch Biologen ZAS are Dr. Katrien Hoet BV, Dr. Peggy Bruynseels BV, Evipa BV, ANISA MESKAL BV, MEDIMAPI BV and DOKTER BRUNO VAN HERENDAEL BV. The shares are held by DR. K. CAMPS (4.8%).
Directors
According to the 2025 annual accounts
Director · represented by Katrien HOET
Director · represented by Peggy BRUYNSEELS
Director · represented by Evelien HEYLEN
Director · represented by Anisa MESKAL
Director · represented by Marian PIQUEUR
Director · represented by Bruno VAN HERENDAEL
DR. NATASJA VAN GASSE, Klinische Biologie BV
Director · represented by Natasja VAN GASSE
Pierre DE SCHOUWER
Director
Director · represented by Katinka SCHATTEMAN
Wim UYTTENBROECK
Director
Director · represented by Boris MAHIEU
Dr. Philippe Willems Klinisch Bioloog BV
Director · represented by Philippe WILLEMS
Director · represented by Sarah MAHIEU
Director · represented by Steven WEEKX
Director · represented by Sigrid VERMEIREN
Klinisch bioloog Walter Verstrepen BV
Director · represented by Walter VERSTREPEN
Director · represented by Sofie SCHOUWERS
Director · represented by Kim CAMPS
Director · represented by Christel VAN DEN EIJNDE
Director · represented by Kristien VER ELST
Shareholders
4.8%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Lindendreef 1
2020 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0803.393.986
- VAT number
- BE 0803.393.986
- Registered office
- Lindendreef 1, 2020 Antwerpen
- Names & denominations
- Klinisch Biologen ZAS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 June 2023
- Peppol
- Active · Active since 17 Jul 2026
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria